Joel Isaacson & Co’s DexCom DXCM Stock Holding History

Joel Isaacson & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$556K	Hold	8,260	–	–	0.02%	288
2026 Q1	$519K	Sell	8,260 -400	-5%	-$27.9K	0.02%	274
2025 Q4	$575K	Hold	8,660	–	–	0.02%	266
2025 Q3	$583K	Hold	8,660	–	–	0.02%	247
2025 Q2	$756K	Hold	8,660	–	–	0.03%	198
2025 Q1	$591K	Hold	8,660	–	–	0.03%	220
2024 Q4	$673K	Hold	8,660	–	–	0.03%	198
2024 Q3	$581K	Hold	8,660	–	–	0.03%	196
2024 Q2	$982K	Hold	8,660	–	–	0.05%	137
2024 Q1	$1.2M	Hold	8,660	–	–	0.07%	120
2023 Q4	$1.07M	Hold	8,660	–	–	0.07%	117
2023 Q3	$808K	Hold	8,660	–	–	0.06%	135
2023 Q2	$1.11M	Sell	8,660 -225	-3%	-$27.2K	0.07%	112
2023 Q1	$1.03M	Hold	8,885	–	–	0.07%	116
2022 Q4	$1.01M	Buy	8,885 +2,085	+31%	+$229K	0.08%	114
2022 Q3	$548K	Hold	6,800	–	–	0.05%	154
2022 Q2	$507K	Hold	6,800	–	–	0.04%	165
2022 Q1	$817K	Sell	6,800 -24	-0.4%	-$2.63K	0.06%	127
2021 Q4	$916K	Buy	6,824 +24	+0.4%	+$3.45K	0.06%	127
2021 Q3	$930K	Hold	6,800	–	–	0.07%	117
2021 Q2	$726K	Sell	6,800 -3,400	-33%	-$327K	0.06%	136
2021 Q1	$916K	Hold	10,200	–	–	0.08%	103
2020 Q4	$943K	Sell	10,200 -2,000	-16%	-$179K	0.09%	94
2020 Q3	$1.26M	Hold	12,200	–	–	0.16%	70
2020 Q2	$1.24M	Sell	12,200 -15,800	-56%	-$1.41M	0.18%	63
2020 Q1	$1.89M	Hold	28,000	–	–	0.33%	35
2019 Q4	$1.53M	Sell	28,000 -3,200	-10%	-$152K	0.2%	51
2019 Q3	$1.16M	Buy	31,200 +5,200	+20%	+$202K	0.17%	59
2019 Q2	$974K	Sell	26,000 -8	-0%	-$251	0.14%	71
2019 Q1	$774K	Hold	26,008	–	–	0.11%	96
2018 Q4	$917K	Buy	26,008 +8	+0%	+$254	0.15%	86
2018 Q3	$930K	Hold	26,000	–	–	0.15%	75
2018 Q2	$617K	Hold	26,000	–	–	0.1%	98
2018 Q1	$482K	Buy	26,000 +8,000	+44%	+$118K	0.08%	115
2017 Q4	$258K	Hold	18,000	–	–	0.04%	167
2017 Q3	$220K	Hold	18,000	–	–	0.04%	172
2017 Q2	$329K	Buy	+18,000	New	+$332K	0.06%	133
2017 Q1	–	Sell	-2,000	Closed	-$30K	–	274
2016 Q4	$30K	Hold	2,000	–	–	0.01%	386
2016 Q3	$44K	Hold	2,000	–	–	0.01%	343
2016 Q2	$40K	Sell	2,000 -400	-17%	-$6.81K	0.01%	358
2016 Q1	$41K	Buy	2,400 +400	+20%	+$6.68K	0.01%	360
2015 Q4	$41K	Buy	2,000 +800	+67%	+$16.6K	0.01%	357
2015 Q3	$26K	Hold	1,200	–	–	0.01%	436
2015 Q2	$24K	Hold	1,200	–	–	0.01%	473
2015 Q1	$19K	Hold	1,200	–	–	﹤0.01%	499
2014 Q4	$17K	Buy	+1,200	New	+$14.7K	﹤0.01%	451

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DCP

DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Joel Isaacson & Co's DXCM Position: Q2 2026 in Review

Joel Isaacson & Co held its DexCom (DXCM) position steady in Q2 2026 at 8,260 shares worth $556K. The position accounts for 0.02% of the portfolio, ranked #288.

Joel Isaacson & Co first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.89M in Q1 2020. 503 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Joel Isaacson & Co held 8,260 shares of DexCom worth $556K as of Q2 2026.
Joel Isaacson & Co left its DexCom share count unchanged in Q2 2026.
DexCom made up 0.02% of Joel Isaacson & Co's portfolio in Q2 2026, its #288 holding.
Joel Isaacson & Co first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
Joel Isaacson & Co's DexCom position peaked at $1.89M in Q1 2020.
503 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.